Publication | Closed Access

The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls

Neurodegenerative DiseasesNormal Healthy ControlsAutoimmune DiseaseNeurological DisorderMedicineImmunologyNeurological ProgressNeuroscienceNeurologyMultiple SclerosisFine SpecificityNeuropathologyNeuroimmunology